참고문헌 (150)

1. All about albumin: biochemistry, genetics, and medical applications Peters T 1996 

2. Comp Cont Educ Pract Vet Throop JL 931 26 12 2004 

3. Anderson, Clark L., Chaudhury, Chaity, Kim, Jonghan, Bronson, C.L., Wani, Manzoor A., Mohanty, Sudhasri. Perspective – FcRn transports albumin: relevance to immunology and medicine. Trends in immunology, vol.27, no.7, 343-348.

   상세보기

4. Kim, Jonghan, Hayton, William L., Robinson, John M., Anderson, Clark L.. Kinetics of FcRn-mediated recycling of IgG and albumin in human: Pathophysiology and therapeutic implications using a simplified mechanism-based model. Clinical immunology : the official journal of the Clinical Immunology Society, vol.122, no.2, 146-155.

   상세보기

5. Sleep, D., Cameron, J., Evans, L.R.. Albumin as a versatile platform for drug half-life extension. Biochimica et biophysica acta, General subjects, vol.1830, no.12, 5526-5534.

   상세보기

6. Dockal, Michael, Carter, Daniel C., Rüker, Florian. The Three Recombinant Domains of Human Serum Albumin. The Journal of biological chemistry, vol.274, no.41, 29303-29310.

   상세보기

7. Fanali, G., di Masi, A., Trezza, V., Marino, M., Fasano, M., Ascenzi, P.. Human serum albumin: From bench to bedside. Molecular aspects of medicine, vol.33, no.3, 209-290.

   상세보기

8. Dockal, Michael, Carter, Daniel C., Rüker, Florian. Conformational Transitions of the Three Recombinant Domains of Human Serum Albumin Depending on pH. The Journal of biological chemistry, vol.275, no.5, 3042-3050.

   상세보기

9. Ghuman, Jamie, Zunszain, Patricia A., Petitpas, Isabelle, Bhattacharya, Ananyo A., Otagiri, Masaki, Curry, Stephen. Structural Basis of the Drug-binding Specificity of Human Serum Albumin. Journal of molecular biology, vol.353, no.1, 38-52.

   상세보기

10. Gundry, Rebekah L., Fu, Qin, Jelinek, Christine A., Van Eyk, Jennifer E., Cotter, Robert J.. Investigation of an albumin-enriched fraction of human serum and its albuminome. Proteomics. Clinical applications, vol.1, no.1, 73-88.

    상세보기

11. Fasano, Mauro, Curry, Stephen, Terreno, Enzo, Galliano, Monica, Fanali, Gabriella, Narciso, Pasquale, Notari, Stefania, Ascenzi, Paolo. The extraordinary ligand binding properties of human serum albumin. IUBMB life, vol.57, no.12, 787-796.

    상세보기

12. Yamasaki, K., Chuang, V.T.G., Maruyama, T., Otagiri, M.. Albumin-drug interaction and its clinical implication. Biochimica et biophysica acta, General subjects, vol.1830, no.12, 5435-5443.

    상세보기

13. Ha, C.E., Bhagavan, N.V.. Novel insights into the pleiotropic effects of human serum albumin in health and disease. Biochimica et biophysica acta, General subjects, vol.1830, no.12, 5486-5493.

    상세보기

14. Varshney, Ankita, Sen, Priyankar, Ahmad, Ejaz, Rehan, Mohd., Subbarao, Naidu, Khan, Rizwan Hasan. Ligand binding strategies of human serum albumin: How can the cargo be utilized?. Chirality : the pharmacological, biological, and chemical consequences of molecular asymmetry, vol.22, no.1, 77-87.

    상세보기

15. Bal, W., Sokolowska, M., Kurowska, E., Faller, P.. Binding of transition metal ions to albumin: Sites, affinities and rates. Biochimica et biophysica acta, General subjects, vol.1830, no.12, 5444-5455.

    상세보기

16. Stewart, Alan J., Blindauer, Claudia A., Berezenko, Stephen, Sleep, Darrell, Tooth, David, Sadler, Peter J.. Role of Tyr84 in controlling the reactivity of Cys34 of human albumin. The FEBS journal, vol.272, no.2, 353-362.

    상세보기

17. Ishima, Y., Kragh-Hansen, U., Maruyama, T., Otagiri, M.. Albumin as a Nitric Oxide-Traffic Protein: Characterization, Biochemistry and Possible Future Therapeutic Applications. Drug metabolism and pharmacokinetics, vol.24, no.4, 308-317.

    상세보기

18. Hamilton, J.A.. NMR reveals molecular interactions and dynamics of fatty acid binding to albumin. Biochimica et biophysica acta, General subjects, vol.1830, no.12, 5418-5426.

    상세보기

19. Curry, Stephen, Mandelkow, Hendrik, Brick, Peter, Franks, Nick. Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites. Nature structural biology, vol.5, no.9, 827-835.

    상세보기

20. Bhattacharya, A.A., Grune, T., Curry, S.. Crystallographic analysis reveals common modes of binding of medium and long-chain fatty acids to human serum albumin. Journal of molecular biology, vol.303, no.5, 721-732.

    상세보기

21. Fujiwara, S.i., Amisaki, T.. Fatty acid binding to serum albumin: Molecular simulation approaches. Biochimica et biophysica acta, General subjects, vol.1830, no.12, 5427-5434.

    상세보기

22. J Lipid Res Saifer A 268 2 3 1961 10.1016/S0022-2275(20)39014-3 

    상세보기

23. Merlot, Angelica M., Kalinowski, Danuta S., Richardson, Des R.. Unraveling the mysteries of serum albumin—more than just a serum protein. Frontiers in physiology, vol.5, 299-.

    상세보기

24. Gradishar, William J. Albumin-bound paclitaxel: a next-generation taxane. Expert opinion on pharmacotherapy, vol.7, no.8, 1041-1053.

    상세보기

25. J Med Sci Malik AB 13 2 1 2009 

26. Amsellem, Sabine, Gburek, Jakub, Hamard, Ghislaine, Nielsen, Rikke, Willnow, Thomas E., Devuyst, Olivier, Nexo, Ebba, Verroust, Pierre J., Christensen, Erik I., Kozyraki, Renata. Cubilin Is Essential for Albumin Reabsorption in the Renal Proximal Tubule. Journal of the American Society of Nephrology : JASN, vol.21, no.11, 1859-1867.

    상세보기

27. Saito, Akihiko, Sato, Hiroyoshi, Iino, Noriaki, Takeda, Tetsuro. Molecular Mechanisms of Receptor-Mediated Endocytosis in the Renal Proximal Tubular Epithelium. Journal of biomedicine & biotechnology, vol.2010, 403272-.

    상세보기

28. Chaudhury, Chaity, Mehnaz, Samina, Robinson, John M., Hayton, William L., Pearl, Dennis K., Roopenian, Derry C., Anderson, Clark L.. The Major Histocompatibility Complex–related Fc Receptor for IgG (FcRn) Binds Albumin and Prolongs Its Lifespan. The Journal of experimental medicine, vol.197, no.3, 315-322.

    상세보기

29. Roopenian, Derry C., Akilesh, Shreeram. FcRn: the neonatal Fc receptor comes of age. Nature reviews. Immunology, vol.7, no.9, 715-725.

    상세보기

30. Andersen, J.T., Sandlie, I.. The Versatile MHC Class I-related FcRn Protects IgG and Albumin from Degradation: Implications for Development of New Diagnostics and Therapeutics. Drug metabolism and pharmacokinetics, vol.24, no.4, 318-332.

    상세보기

31. Baker, Kristi, Qiao, Shuo-Wang, Kuo, Timothy, Kobayashi, Kanna, Yoshida, Masaru, Lencer, Wayne I., Blumberg, Richard S.. Immune and non-immune functions of the (not so) neonatal Fc receptor, FcRn. Seminars in Immunopathology, vol.31, no.2, 223-236.

    상세보기

32. Kuo, Timothy T., Baker, Kristi, Yoshida, Masaru, Qiao, Shuo-Wang, Aveson, Victoria G., Lencer, Wayne I., Blumberg, Richard S.. Neonatal Fc Receptor: From Immunity to Therapeutics. Journal of clinical immunology, vol.30, no.6, 777-789.

    상세보기

33. Roopenian, Derry C., Sun, Victor Z.. Clinical Ramifications of the MHC Family Fc Receptor FcRn. Journal of clinical immunology, vol.30, no.6, 790-797.

    상세보기

34. Chaudhury, C., Brooks, C. L., Carter, D. C., Robinson, J. M., Anderson, C. L.. Albumin Binding to FcRn: Distinct from the FcRn−IgG Interaction. Biochemistry, vol.45, no.15, 4983-4990.

    상세보기

35. Rath, Timo, Kuo, Timothy T., Baker, Kristi, Qiao, Shuo-Wang, Kobayashi, Kanna, Yoshida, Masaru, Roopenian, Derry, Fiebiger, Edda, Lencer, Wayne I., Blumberg, Richard S.. The Immunologic Functions of the Neonatal Fc Receptor for IgG. Journal of clinical immunology, vol.33, no.suppl1, 9-17.

    상세보기

36. Simister, Neil E., Mostov, Keith E.. An Fc receptor structurally related to MHC class I antigens. Nature, vol.337, no.6203, 184-187.

    상세보기

37. Burmeister, Wilhelm P., Gastinel, Louis N., Simister, Neil E., Blum, Michael L., Bjorkman, Pamela J.. Crystal structure at 2.2 Å resolution of the MHC-related neonatal Fc receptor. Nature, vol.372, no.6504, 336-343.

    상세보기

38. West Jr., A. P., Bjorkman, P. J.. Crystal Structure and Immunoglobulin G Binding Properties of the Human Major Histocompatibility Complex-Related Fc Receptor^,. Biochemistry, vol.39, no.32, 9698-9708.

    상세보기

39. Gastinel, L N, Simister, N E, Bjorkman, P J. Expression and crystallization of a soluble and functional form of an Fc receptor related to class I histocompatibility molecules.. Proceedings of the National Academy of Sciences of the United States of America, vol.89, no.2, 638-642.

    상세보기

40. Wani, Manzoor A., Haynes, Lynn D., Kim, Jonghan, Bronson, C. L., Chaudhury, Chaity, Mohanty, Sudhasri, Waldmann, Thomas A., Robinson, John M., Anderson, Clark L.. Familial hypercatabolic hypoproteinemia caused by deficiency of the neonatal Fc receptor, FcRn, due to a mutant β₂-microglobulin gene. Proceedings of the National Academy of Sciences of the United States of America, vol.103, no.13, 5084-5089.

    상세보기

41. Waldmann, T A, Terry, W D. Familial hypercatabolic hypoproteinemia. A disorder of endogenous catabolism of albumin and immunoglobulin.. The Journal of clinical investigation, vol.86, no.6, 2093-2098.

    상세보기

42. Terje Andersen, Jan, Bekele Daba, Muluneh, Berntzen, Gøril, Michaelsen, Terje E., Sandlie, Inger. Cross-species Binding Analyses of Mouse and Human Neonatal Fc Receptor Show Dramatic Differences in Immunoglobulin G and Albumin Binding. The Journal of biological chemistry, vol.285, no.7, 4826-4836.

    상세보기

43. Andersen, Jan Terje, Dalhus, Bjørn, Cameron, Jason, Daba, Muluneh Bekele, Plumridge, Andrew, Evans, Leslie, Brennan, Stephan O., Gunnarsen, Kristin Støen, Bjørås, Magnar, Sleep, Darrell, Sandlie, Inger. Structure-based mutagenesis reveals the albumin-binding site of the neonatal Fc receptor. Nature communications, vol.3, 610-.

    상세보기

44. Schmidt, Michael M., Townson, Sharon A., Andreucci, Amy J., King, Bracken M., Schirmer, Emily B., Murillo, Alec J., Dombrowski, C., Tisdale, Alison W., Lowden, Patricia A., Masci, Allyson L., Kovalchin, Joseph T., Erbe, David V., Wittrup, K., Furfine, Eric S., Barnes, Thomas M.. Crystal Structure of an HSA/FcRn Complex Reveals Recycling by Competitive Mimicry of HSA Ligands at a pH-Dependent Hydrophobic Interface. Structure, vol.21, no.11, 1966-1978.

    상세보기

45. Sand, Kine Marita Knudsen, Dalhus, Bjørn, Christianson, Gregory J., Bern, Malin, Foss, Stian, Cameron, Jason, Sleep, Darrell, Bjørås, Magnar, Roopenian, Derry C., Sandlie, Inger, Andersen, Jan Terje. Dissection of the Neonatal Fc Receptor (FcRn)-Albumin Interface Using Mutagenesis and Anti-FcRn Albumin-blocking Antibodies. The Journal of biological chemistry, vol.289, no.24, 17228-17239.

    상세보기

46. Oganesyan, Vaheh, Damschroder, Melissa M., Cook, Kimberly E., Li, Qing, Gao, Changshou, Wu, Herren, Dall'Acqua, William F.. Structural Insights into Neonatal Fc Receptor-based Recycling Mechanisms. The Journal of biological chemistry, vol.289, no.11, 7812-7824.

    상세보기

47. Andersen, Jan Terje, Dalhus, Bjørn, Viuff, Dorthe, Ravn, Birgitte Thue, Gunnarsen, Kristin Støen, Plumridge, Andrew, Bunting, Karen, Antunes, Filipa, Williamson, Rebecca, Athwal, Steven, Allan, Elizabeth, Evans, Leslie, Bjørås, Magnar, Kjærulff, Søren, Sleep, Darrell, Sandlie, Inger, Cameron, Jason. Extending Serum Half-life of Albumin by Engineering Neonatal Fc Receptor (FcRn) Binding. The Journal of biological chemistry, vol.289, no.19, 13492-13502.

    상세보기

48. Kragh-Hansen, U., Minchiotti, L., Galliano, M., Peters, T.. Human serum albumin isoforms: Genetic and molecular aspects and functional consequences. Biochimica et biophysica acta, General subjects, vol.1830, no.12, 5405-5417.

    상세보기

49. Minchiotti, Lorenzo, Galliano, Monica, Kragh-Hansen, Ulrich, Peters Jr., Theodore. Mutations and polymorphisms of the gene of the major human blood protein, serum albumin. Human mutation, vol.29, no.8, 1007-1016.

    상세보기

50. Bosse, Dietrich, Praus, Michaela, Kiessling, Peter, Nyman, Lars, Andresen, Corina, Waters, Joanne, Schindel, Fritz. Phase I Comparability of Recombinant Human Albumin and Human Serum Albumin. The Journal of clinical pharmacology, vol.45, no.1, 57-67.

    상세보기

51. Sansonno, D.E., DeTomaso, P., Papanice, M.A., Manghisi, O.G.. An enzyme-linked immunosorbent assay for the detection of autoantibodies to albumin. Journal of immunological methods, vol.90, no.1, 131-136.

    상세보기

52. Gregor, I., Iberg, N., Berger, W., Fl�ckiger, R.. Albumin-directed antibodies in diabetes: demonstration of human serum albumin-directed IgM autoantibodies. Diabetologia, vol.29, no.8, 481-484.

    상세보기

53. Baraldini, Mario, Miglio, Federico, Cursaro, Carmela, Stefanini, Giuseppe Francesco, Andreone, Pietro, Micaletti, Enzo, Gasbarrini, Giovanni. Clinical significance of antibodies to polymerized human albumin detected by enzyme-linked immunosorbent assay. La Ricerca in clinica e in laboratorio, vol.18, no.4, 291-300.

    상세보기

54. Chapman, Joab, Maayan, Channa, Michaelson, Daniel M.. Antibodies to Human Serum Albumin in Familial Dysautonomia. International archives of allergy and immunology, vol.100, no.1, 42-46.

    상세보기

55. Pires, Eusebio S., Parte, Priyanka P., Meherji, Perveen K., Khan, Shagufta A., Khole, Vrinda V.. Naturally Occurring Anti-albumin Antibodies Are Responsible for False Positivity in Diagnosis of Autoimmune Premature Ovarian Failure. The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society, vol.54, no.4, 397-405.

    상세보기

56. Khan, Mohd. Wajid Ali, Qadrie, Zulfkar Latief, Khan, Wahid Ali. Antibodies against Gluco-Oxidatively Modified Human Serum Albumin Detected in Diabetes-Associated Complications. International archives of allergy and immunology, vol.153, no.2, 207-214.

    상세보기

57. SJÖWALL, CHRISTOPHER, KASTBOM, ALF, ALMROTH, GUNNEL, WETTERÖ, JONAS, SKOGH, THOMAS. Beware of Antibodies to Dietary Proteins in “Antigen-specific” Immunoassays! Falsely Positive Anticytokine Antibody Tests Due to Reactivity with Bovine Serum Albumin in Rheumatoid Arthritis (The Swedish TIRA Project). The Journal of rheumatology, vol.38, no.2, 215-220.

    상세보기

58. Chen, Z., He, Y., Shi, B., Yang, D.. Human serum albumin from recombinant DNA technology: Challenges and strategies. Biochimica et biophysica acta, General subjects, vol.1830, no.12, 5515-5525.

    상세보기

59. Biotechnol Appl Biochem Dodsworth N 171 24 2 1996 10.1111/j.1470-8744.1996.tb00397.x 

    상세보기

60. Kobayashi, Kaoru. Summary of recombinant human serum albumin development. Biologicals : journal of the International Association of Biological Standardization, vol.34, no.1, 55-59.

    상세보기

61. Blindauer, Claudia A., Harvey, Ian, Bunyan, Kerry E., Stewart, Alan J., Sleep, Darrell, Harrison, David J., Berezenko, Stephen, Sadler, Peter J.. Structure, Properties, and Engineering of the Major Zinc Binding Site on Human Albumin. The Journal of biological chemistry, vol.284, no.34, 23116-23124.

    상세보기

62. Komatsu, T., Ohmichi, N., Nakagawa, A., Zunszain, P. A., Curry, S., Tsuchida, E.. O₂ and CO Binding Properties of Artificial Hemoproteins Formed by Complexing Iron Protoporphyrin IX with Human Serum Albumin Mutants. Journal of the American Chemical Society, vol.127, no.45, 15933-15942.

    상세보기

63. Iwao, Yasunori, Hiraike, Mikako, Kragh-Hansen, Ulrich, Kawai, Keiichi, Suenaga, Ayaka, Maruyama, Toru, Otagiri, Masaki. Altered chain-length and glycosylation modify the pharmacokinetics of human serum albumin. Biochimica et biophysica acta. Proteins and proteomics, vol.1794, no.4, 634-641.

    상세보기

64. Sheffield, William P, Marques, Janey A, Bhakta, Varsha, Smith, Ian J. Modulation of Clearance of Recombinant Serum Albumin by Either Glycosylation or Truncation. Thrombosis research, vol.99, no.6, 613-621.

    상세보기

65. Nakajou, Keisuke, Watanabe, Hiroshi, Kragh-Hansen, Ulrich, Maruyama, Toru, Otagiri, Masaki. The effect of glycation on the structure, function and biological fate of human serum albumin as revealed by recombinant mutants. Biochimica et biophysica acta, General subjects, vol.1623, no.2, 88-97.

    상세보기

66. Iwao, Yasunori, Anraku, Makoto, Yamasaki, Keishi, Kragh-Hansen, Ulrich, Kawai, Keiichi, Maruyama, Toru, Otagiri, Masaki. Oxidation of Arg-410 promotes the elimination of human serum albumin. Biochimica et biophysica acta. Proteins and proteomics, vol.1764, no.4, 743-749.

    상세보기

67. Iwao, Yasunori, Hiraike, Mikako, Kragh-Hansen, Ulrich, Mera, Katsumi, Noguchi, Taishi, Anraku, Makoto, Kawai, Keiichi, Maruyama, Toru, Otagiri, Masaki. Changes of net charge and α-helical content affect the pharmacokinetic properties of human serum albumin. Biochimica et biophysica acta. Proteins and proteomics, vol.1774, no.12, 1582-1590.

    상세보기

68. J Biol Chem Schnitzer JE 24544 267 34 1992 10.1016/S0021-9258(18)35799-5 

    상세보기

69. J Biol Chem Schnitzer JE 7562 268 10 1993 10.1016/S0021-9258(18)53212-9 

    상세보기

70. Elsadek, Bakheet, Kratz, Felix. Impact of albumin on drug delivery — New applications on the horizon. Journal of controlled release : official journal of the Controlled Release Society, vol.157, no.1, 4-28.

    상세보기

71. Kratz, F., Elsadek, B.. Clinical impact of serum proteins on drug delivery. Journal of controlled release : official journal of the Controlled Release Society, vol.161, no.2, 429-445.

    상세보기

72. Trüssel, Sabrina, Dumelin, Christoph, Frey, Katharina, Villa, Alessandra, Buller, Fabian, Neri, Dario. New Strategy for the Extension of the Serum Half-Life of Antibody Fragments. Bioconjugate chemistry, vol.20, no.12, 2286-2292.

    상세보기

73. Zobel, Kerry, Koehler, Michael F.T., Beresini, Maureen H., Caris, Lisa D., Combs, Daniel. Phosphate ester serum albumin affinity tags greatly improve peptide half-life in vivo. Bioorganic & medicinal chemistry letters, vol.13, no.9, 1513-1515.

    상세보기

74. Home, Philip, Kurtzhals, Peter. Insulin detemir: from concept to clinical experience. Expert opinion on pharmacotherapy, vol.7, no.3, 325-343.

    상세보기

75. Kurtzhals, P, Havelund, S, Jonassen, I, Kiehr, B, Larsen, U D, Ribel, U, Markussen, J. Albumin binding of insulins acylated with fatty acids: characterization of the ligand-protein interaction and correlation between binding affinity and timing of the insulin effect in vivo. The Biochemical journal, vol.312, no.3, 725-731.

    상세보기

76. Gough, S. C. L., Harris, S., Woo, V., Davies, M.. Insulin degludec: overview of a novel ultra long‐acting basal insulin. Diabetes, obesity & metabolism, vol.15, no.4, 301-309.

    상세보기

77. Bode, B.. An overview of the pharmacokinetics, efficacy and safety of liraglutide. Diabetes research and clinical practice, vol.97, no.1, 27-42.

    상세보기

78. Diabetes Metab Syndr Obes Rigato M 107 7 2014 

    상세보기

79. Ryan, G.J., Foster, K.T., Jobe, L.J.. Review of the Therapeutic Uses of Liraglutide. Clinical therapeutics, vol.33, no.7, 793-811.

    상세보기

80. Gotfredsen, Carsten F., Mølck, Anne-Marie, Thorup, Inger, Nyborg, Niels C. Berg, Salanti, Zaki, Knudsen, Lotte Bjerre, Larsen, Marianne O.. The Human GLP-1 Analogs Liraglutide and Semaglutide: Absence of Histopathological Effects on the Pancreas in Nonhuman Primates. Diabetes, vol.63, no.7, 2486-2497.

    상세보기

81. Zheng, Yao-Rong, Suntharalingam, Kogularamanan, Johnstone, Timothy C., Yoo, Hyunsuk, Lin, Wei, Brooks, Jamar G., Lippard, Stephen J.. Pt(IV) Prodrugs Designed to Bind Non-Covalently to Human Serum Albumin for Drug Delivery. Journal of the American Chemical Society, vol.136, no.24, 8790-8798.

    상세보기

82. 10.1002/9781118354599.ch11 

    

83. Jonsson, A., Dogan, J., Herne, N., Abrahmsen, L., Nygren, P.-A.. Engineering of a femtomolar affinity binding protein to human serum albumin. Protein engineering, design & selection : PEDS, vol.21, no.8, 515-527.

    상세보기

84. Nilvebrant, Johan, Hober, Sophia. The albumin-binding domain as a scaffold for protein engineering. Computational and structural biotechnology journal, vol.6, no.7, e201303009-.

    상세보기

85. Angelini, Alessandro, Morales-Sanfrutos, Julia, Diderich, Philippe, Chen, Shiyu, Heinis, Christian. Bicyclization and Tethering to Albumin Yields Long-Acting Peptide Antagonists. Journal of medicinal chemistry, vol.55, no.22, 10187-10197.

    상세보기

86. Dennis, Mark S., Zhang, Min, Meng, Y. Gloria, Kadkhodayan, Miryam, Kirchhofer, Daniel, Combs, Dan, Damico, Lisa A.. Albumin Binding as a General Strategy for Improving the Pharmacokinetics of Proteins. The Journal of biological chemistry, vol.277, no.38, 35035-35043.

    상세보기

87. Nguyen, Allen, Reyes II, Arthur E., Zhang, Min, McDonald, Paul, Wong, Wai Lee T., Damico, Lisa A., Dennis, Mark S.. The pharmacokinetics of an albumin-binding Fab (AB.Fab) can be modulated as a function of affinity for albumin. Protein engineering, design & selection : PEDS, vol.19, no.7, 291-297.

    상세보기

88. Holt, Lucy J, Basran, Amrik, Jones, Kate, Chorlton, Jennifer, Jespers, Laurent S, Brewis, Neil D, Tomlinson, Ian M. Anti-serum albumin domain antibodies for extending the half-lives of short lived drugs.. Protein engineering, design & selection : PEDS, vol.21, no.5, 283-288.

    상세보기

89. Tijink, Bernard M., Laeremans, Toon, Budde, Marianne, Walsum, Marijke Stigter-van, Dreier, Torsten, de Haard, Hans J., Leemans, C. René, van Dongen, Guus A.M.S.. Improved tumor targeting of anti-epidermal growth factor receptor Nanobodies through albumin binding: taking advantage of modular Nanobody technology. Molecular cancer therapeutics, vol.7, no.8, 2288-2297.

    상세보기

90. Roovers, Rob C., Laeremans, Toon, Huang, Lieven, De Taeye, Severine, Verkleij, Arie J., Revets, Hilde, de Haard, Hans J., van Bergen en Henegouwen, Paul M. P.. Efficient inhibition of EGFR signalling and of tumour growth by antagonistic anti-EGFR Nanobodies. Cancer immunology, immunotherapy : CII, vol.56, no.3, 303-317.

    상세보기

91. Lipovšek, D.. Adnectins: engineered target-binding protein therapeutics. Protein engineering, design & selection : PEDS, vol.24, no.1, 3-9.

    상세보기

92. Levy, Odile E., Jodka, Carolyn M., Ren, Shijun Steven, Mamedova, Lala, Sharma, Abhinandini, Samant, Manoj, D’Souza, Lawrence J., Soares, Christopher J., Yuskin, Diane R., Jin, Li Jenny, Parkes, David G., Tatarkiewicz, Krystyna, Ghosh, Soumitra S.. Novel Exenatide Analogs with Peptidic Albumin Binding Domains: Potent Anti-Diabetic Agents with Extended Duration of Action. PloS one, vol.9, no.2, e87704-.

    상세보기

93. Paige, Aimee Guider, Whitcomb, K. Lane, Liu, Jennifer, Kinstler, Olaf. Prolonged Circulation of Recombinant Human Granulocyte–Colony Stimulating Factor by Covalent Linkage to Albumin Through a Heterobifunctional Polyethylene Glycol. Pharmaceutical research, vol.12, no.12, 1883-1888.

    상세보기

94. Leger, R., Benquet, C., Huang, X., Quraishi, O., van Wyk, P., Bridon, D.. Kringle 5 peptide-albumin conjugates with anti-migratory activity. Bioorganic & medicinal chemistry letters, vol.14, no.4, 841-845.

    상세보기

95. Simon, Manuel, Frey, Raphael, Zangemeister-Wittke, Uwe, Plückthun, Andreas. Orthogonal Assembly of a Designed Ankyrin Repeat Protein–Cytotoxin Conjugate with a Clickable Serum Albumin Module for Half-Life Extension. Bioconjugate chemistry, vol.24, no.11, 1955-1966.

    상세보기

96. Stoddart, Cheryl A., Nault, Geneviève, Galkina, Sofiya A., Thibaudeau, Karen, Bakis, Peter, Bousquet-Gagnon, Nathalie, Robitaille, Martin, Bellomo, Maryanne, Paradis, Véronique, Liscourt, Patricia, Lobach, Alexandra, Rivard, Marie-Ève, Ptak, Roger G., Mankowski, Marie K., Bridon, Dominique, Quraishi, Omar. Albumin-conjugated C34 Peptide HIV-1 Fusion Inhibitor : EQUIPOTENT TO C34 AND T-20 IN VITRO WITH SUSTAINED ACTIVITY IN SCID-HU THY/LIV MICE. The Journal of biological chemistry, vol.283, no.49, 34045-34052.

    상세보기

97. Thibaudeau, K., Leger, R., Huang, X., Robitaille, M., Quraishi, O., Soucy, C., Bousquet-Gagnon, N., van Wyk, P., Paradis, V., Castaigne, J.-P., Bridon, D.. Synthesis and Evaluation of Insulin−Human Serum Albumin Conjugates. Bioconjugate chemistry, vol.16, no.4, 1000-1008.

    상세보기

98. Holmes, D. L., Thibaudeau, K., L'Archeveque, B., Milner, P. G., Ezrin, A. M., Bridon, D. P.. Site Specific 1:1 Opioid:Albumin Conjugate with in Vitro Activity and Long in Vivo Duration. Bioconjugate chemistry, vol.11, no.4, 439-444.

    상세보기

99. Ehrlich, George K., Michel, Hanspeter, Truitt, Theresa, Riboulet, William, Pop-Damkov, Petar, Goelzer, Petra, Hainzl, Dominik, Qureshi, Farooq, Lueckel, Barbara, Danho, Waleed, Conde-Knape, Karin, Konkar, Anish. Preparation and Characterization of Albumin Conjugates of a Truncated Peptide YY Analogue for Half-Life Extension. Bioconjugate chemistry, vol.24, no.12, 2015-2024.

    상세보기

100. Conju Chem Curr Opin Investig Drugs Giannoukakis N 1245 4 10 2003 

101. Kim, Jung-Guk, Baggio, Laurie L., Bridon, Dominique P., Castaigne, Jean-Paul, Robitaille, Martin F., Jetté, Lucie, Benquet, Corinne, Drucker, Daniel J.. Development and Characterization of a Glucagon-Like Peptide 1-Albumin Conjugate. Diabetes, vol.52, no.3, 751-759.

     상세보기

102. Léger, Roger, Thibaudeau, Karen, Robitaille, Martin, Quraishi, Omar, van Wyk, Pieter, Bousquet-Gagnon, Nathalie, Carette, Julie, Castaigne, Jean-Paul, Bridon, Dominique P.. Identification of CJC-1131-albumin bioconjugate as a stable and bioactive GLP-1(7–36) analog. Bioorganic & medicinal chemistry letters, vol.14, no.17, 4395-4398.

     상세보기

103. Baggio, L.L., Huang, Q., Cao, X., Drucker, D.J.. An Albumin-Exendin-4 Conjugate Engages Central and Peripheral Circuits Regulating Murine Energy and Glucose Homeostasis. Gastroenterology, vol.134, no.4, 1137-1147.

     상세보기

104. 10.1002/9781118354599.ch10 

     

105. Shi, Shuai, Liu, Jing, Joshi, Sangeeta B., Krasnoperov, Valery, Gill, Parkash, Middaugh, C. Russell, Volkin, David B.. Biophysical characterization and stabilization of the recombinant albumin fusion protein sEphB4–HSA. Journal of pharmaceutical sciences : a publication of the American Pharmaceutical Association, vol.101, no.6, 1969-1984.

     상세보기

106. Cordes, Amanda A., Carpenter, John F., Randolph, Theodore W.. Selective domain stabilization as a strategy to reduce human serum albumin–human granulocyte colony stimulating factor aggregation rate. Journal of pharmaceutical sciences : a publication of the American Pharmaceutical Association, vol.101, no.6, 2009-2016.

     상세보기

107. Cordes, Amanda A., Platt, Christopher W., Carpenter, John F., Randolph, Theodore W.. Selective domain stabilization as a strategy to reduce fusion protein aggregation. Journal of pharmaceutical sciences : a publication of the American Pharmaceutical Association, vol.101, no.4, 1400-1409.

     상세보기

108. Rustgi, Vinod K.. Albinterferon alfa-2b, a novel fusion protein of human albumin and human interferon alfa-2b, for chronic hepatitis C. Current medical research and opinion : CMRO, vol.25, no.4, 991-1002.

     상세보기

109. Patient Prefer Adherence Woodward HN 789 8 2014 

     상세보기

110. Cousens, Leslie P., Najafian, Nader, Mingozzi, Federico, Elyaman, Wassim, Mazer, Bruce, Moise, Leonard, Messitt, Timothy J., Su, Yan, Sayegh, Mohamed, High, Katherine, Khoury, Samia J., Scott, David W., De Groot, Anne S.. In Vitro and In Vivo Studies of IgG-derived Treg Epitopes (Tregitopes): A Promising New Tool for Tolerance Induction and Treatment of Autoimmunity. Journal of clinical immunology, vol.33, no.suppl1, 43-49.

     상세보기

111. 10.1586/1744666X.2013.858602 

     

112. Sleep D. Veltis® - Engineered albumins for optimized drug dosing. 2014. Available from: http://www.slideshare.net/NiklasAndersson6/novozymes-veltis-an-innovative-platform-technology-for-the-half-life-extension-of-biotherapeutics-2014-april [Cited 9 December 2014] 

113. Neumann, Elena, Frei, Eva, Funk, Dorothee, Becker, Matthias D, Schrenk, Hans-Hermann, Müller-Ladner, Ulf, Fiehn, Christoph. Native albumin for targeted drug delivery. Expert opinion on drug delivery, vol.7, no.8, 915-925.

     상세보기

114. Yewale, Chetan, Baradia, Dipesh, Vhora, Imran, Misra, Ambikanandan. Proteins: emerging carrier for delivery of cancer therapeutics. Expert opinion on drug delivery, vol.10, no.10, 1429-1448.

     상세보기

115. Kratz, F.. Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles. Journal of controlled release : official journal of the Controlled Release Society, vol.132, no.3, 171-183.

     상세보기

116. Stehle, Gerd, Sinn, Hannsjörg, Wunder, Andreas, Schrenk, Hans Hermann, Stewart, J.Charles M., Hartung, Gernot, Maier-Borst, Wolfgang, Heene, Dieter Ludwig. Plasma protein (albumin) catabolism by the tumor itself—implications for tumor metabolism and the genesis of cachexia. Critical reviews in oncology/hematology, vol.26, no.2, 77-100.

     상세보기

117. Kratz, F.. A clinical update of using albumin as a drug vehicle - A commentary. Journal of controlled release : official journal of the Controlled Release Society, vol.190, 331-336.

     상세보기

118. J Clin Invest Said N 751 123 2 2013 

     상세보기

119. Cardone, Rosa A., Casavola, Valeria, Reshkin, Stephan J.. The role of disturbed pH dynamics and the Na⁺/H⁺ exchanger in metastasis. Nature reviews. Cancer, vol.5, no.10, 786-795.

     상세보기

120. Neurol Res Kremer P 481 22 5 2000 10.1080/01616412.2000.11740705 

     상세보기

121. Ding, Reinhard, Frei, Eva, Fardanesh, Mahmoudreza, Schrenk, Hans-Hermann, Kremer, Paul, Haefeli, Walter E.. Pharmacokinetics of 5-Aminofluorescein-Albumin, a Novel Fluorescence Marker of Brain Tumors During Surgery. The Journal of clinical pharmacology, vol.51, no.5, 672-678.

     상세보기

122. Ishima, Yu, Chen, Di, Fang, Jun, Maeda, Hiroshi, Minomo, Ai, Kragh-Hansen, Ulrich, Kai, Toshiya, Maruyama, Toru, Otagiri, Masaki. S-NitrosatedHuman Serum AlbuminDimer is not only a Novel Anti-Tumor Drug but also a Potentiator forAnti-Tumor Drugs with Augmented EPR Effects. Bioconjugate chemistry, vol.23, no.2, 264-271.

     상세보기

123. Ishima, Yu, Kragh-Hansen, Ulrich, Maruyama, Toru, Otagiri, Masaki. Poly- S -Nitrosated Albumin as a Safe and Effective Multifunctional Antitumor Agent: Characterization, Biochemistry and Possible Future Therapeutic Applications. BioMed research international, vol.2013, 353892-.

     상세보기

124. Stehle, Gerd, Sinn, Hannsj??rg, Wunder, Andreas, Schrenk, Hans Herrmann, Sch??tt, Sandra, Maier-Borst, Wolfgang, Heene, Dieter Ludwig. The loading rate determines tumor targeting properties of methotrexate albumin conjugates in rats :. Anti-cancer drugs, vol.8, no.7, 667-685.

     상세보기

125. Warnecke, André, Fichtner, Iduna, Saß, Gretel, Kratz, Felix. Synthesis, Cleavage Profile, and Antitumor Efficacy of an Albumin-Binding Prodrug of Methotrexate that is Cleaved by Plasmin and Cathepsin B. Archiv der Pharmazie, vol.340, no.8, 389-395.

     상세보기

126. Fiehn, C, Kratz, F, Sass, G, Muller-Ladner, U, Neumann, E. Targeted drug delivery by in vivo coupling to endogenous albumin: an albumin-binding prodrug of methotrexate (MTX) is better than MTX in the treatment of murine collagen-induced arthritis. Annals of the rheumatic diseases : the official journal, vol.67, no.8, 1188-1191.

     상세보기

127. Invest New Drugs Mita MM 2014 

128. Singla, Anil K, Garg, Alka, Aggarwal, Deepika. Paclitaxel and its formulations. International journal of pharmaceutics, vol.235, no.1, 179-192.

     상세보기

129. Gelderblom, H, Verweij, J, Nooter, K, Sparreboom, A. Cremophor EL : the drawbacks and advantages of vehicle selection for drug formulation. European journal of cancer, vol.37, no.13, 1590-1598.

     상세보기

130. Socinski, Mark A., Bondarenko, Igor, Karaseva, Nina A., Makhson, Anatoly M., Vynnychenko, Igor, Okamoto, Isamu, Hon, Jeremy K., Hirsh, Vera, Bhar, Paul, Zhang, Hui, Iglesias, Jose L., Renschler, Markus F.. Weekly nab-Paclitaxel in Combination With Carboplatin Versus Solvent-Based Paclitaxel Plus Carboplatin as First-Line Therapy in Patients With Advanced Non-Small-Cell Lung Cancer: Final Results of a Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol.30, no.17, 2055-2062.

     상세보기

131. Lluch, A., Alvarez, I., Munoz, M., Segui, M.A., Tusquets, I., Garcia-Estevez, L.. Treatment innovations for metastatic breast cancer: Nanoparticle albumin-bound (NAB) technology targeted to tumors. Critical reviews in oncology/hematology, vol.89, no.1, 62-72.

     상세보기

132. Al-Batran, Salah-Eddin, Geissler, Michael, Seufferlein, Thomas, Oettle, Helmut. Nab-Paclitaxel for Metastatic Pancreatic Cancer: Clinical Outcomes and Potential Mechanisms of Action. Oncology research and treatment, vol.37, no.3, 128-134.

     상세보기

133. Cecco, Sara, Aliberti, Maria, Baldo, Paolo, Giacomin, Elisa, Leone, Roberto. Safety and efficacy evaluation of albumin-bound paclitaxel. Expert opinion on drug safety, vol.13, no.4, 511-520.

     상세보기

134. Expert Opin Drug Saf Kudlowitz D 681 13 6 2014 

135. Desai, Neil. Challenges in Development of Nanoparticle-Based Therapeutics. The AAPS journal, vol.14, no.2, 282-295.

     상세보기

136. Li, C., Li, Y., Gao, Y., Wei, N., Zhao, X., Wang, C., Li, Y., Xiu, X., Cui, J.. Direct comparison of two albumin-based paclitaxel-loaded nanoparticle formulations: Is the crosslinked version more advantageous?. International journal of pharmaceutics, vol.468, no.1, 15-25.

     상세보기

137. Bioconjug Chem Byeon HJ 2014 

138. Liu, Mengyuan, Huang, Yi, Hu, Lei, Liu, Guoping, Hu, Xueping, Liu, Dongxu, Yang, Xiaosong. Selective delivery of interleukine-1 receptor antagonist to inflamed joint by albumin fusion. BMC biotechnology, vol.12, 68-68.

     상세보기

139. Int J Nanomedicine Pang Z 3421 7 2012 

140. Fiume, Luigi, Di Stefano, Giuseppina. Lactosaminated human albumin, a hepatotropic carrier of drugs. European journal of pharmaceutical sciences, vol.40, no.4, 253-262.

     상세보기

141. Danhier, Fabienne, Le Breton, Aude, Préat, Véronique. RGD-Based Strategies To Target Alpha(v) Beta(3) Integrin in Cancer Therapy and Diagnosis. Molecular pharmaceutics, vol.9, no.11, 2961-2973.

     상세보기

142. Temming, K., Meyer, D. L., Zabinski, R., Dijkers, E. C. F., Poelstra, K., Molema, G., Kok, R. J.. Evaluation of RGD-Targeted Albumin Carriers for Specific Delivery of Auristatin E to Tumor Blood Vessels. Bioconjugate chemistry, vol.17, no.6, 1385-1394.

     상세보기

143. Temming, Kai., Meyer, Damon L., Zabinski, Roger., Senter, Peter D., Poelstra, Klaas., Molema, Grietje., Kok, Robbert J.. Improved Efficacy of α_vβ₃-Targeted Albumin Conjugates by Conjugation of a Novel Auristatin Derivative. Molecular pharmaceutics, vol.4, no.5, 686-694.

     상세보기

144. Yazaki, P.J., Kassa, T., Cheung, C.w., Crow, D.M., Sherman, M.A., Bading, J.R., Anderson, A.L.J., Colcher, D., Raubitschek, A.. Biodistribution and tumor imaging of an anti-CEA single-chain antibody-albumin fusion protein. Nuclear medicine and biology, vol.35, no.2, 151-158.

     상세보기

145. Bri J Cancer Huhalov A S63 91 2004 

146. Altintas, I., Heukers, R., van der Meel, R., Lacombe, M., Amidi, M., van Bergen en Henegouwen, P.M.P., Hennink, W.E., Schiffelers, R.M., Kok, R.J.. Nanobody-albumin nanoparticles (NANAPs) for the delivery of a multikinase inhibitor 17864 to EGFR overexpressing tumor cells. Journal of controlled release : official journal of the Controlled Release Society, vol.165, no.2, 110-118.

     상세보기

147. Ji, Shunrong, Xu, Jin, Zhang, Bo, Yao, Wantong, Xu, Wenyan, Wu, Wenzhe, Xu, Yongfeng, Wang, Hao, Ni, Quanxing, Hou, Huimin, Yu, Xianjun. RGD-conjugated albumin nanoparticles as a novel delivery vehicle in pancreatic cancer therapy.. Cancer biology & therapy, vol.13, no.4, 206-215.

     상세보기

148. 10.1002/9781118354599.ch7 

     

149. Pridgen, Eric M., Alexis, Frank, Kuo, Timothy T., Levy-Nissenbaum, Etgar, Karnik, Rohit, Blumberg, Richard S., Langer, Robert, Farokhzad, Omid C.. Transepithelial Transport of Fc-Targeted Nanoparticles by the Neonatal Fc Receptor for Oral Delivery. Science translational medicine, vol.5, no.213, 213ra167-213ra167.

     상세보기

150. Ye, Lilin, Zeng, Rongyu, Bai, Yu, Roopenian, Derry C., Zhu, Xiaoping. Efficient Mucosal Delivery of Vaccine Using the FcRn-Mediated IgG Transfer Pathway. Nature biotechnology, vol.29, no.2, 158-163.

     상세보기